Related Experiment Video
Updated: Aug 5, 2026
04:01
Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
Published on: September 15, 2023
[Complete resection for giant thymic carcinoma after simultaneous combination chemotherapy]
Tomoyuki Ueki1, Y Ueshima, H Kurioka
1Department of Surgery, Kyoto First Red Cross Hospital, Kyoto, Japan.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|April 15, 2005
Summary
Advanced thymic carcinoma in a young man showed significant tumor reduction after neoadjuvant chemotherapy with the ADOC regimen (carboplatin, doxorubicin, vincristine, cyclophosphamide), enabling complete surgical resection.
Area of Science:
- Oncology
- Thoracic Surgery
- Medical Imaging
Background:
- Thymic carcinoma is a rare mediastinal malignancy.
- Early diagnosis and treatment are crucial for patient outcomes.
- Invasive thymoma requires multimodal treatment strategies.
Observation:
- A 19-year-old male presented with dyspnea and a large anterior mediastinal mass.
- Imaging revealed a huge mass, diagnosed as invasive thymoma via needle biopsy.
- The patient received neoadjuvant chemotherapy with the ADOC regimen.
Findings:
- The neoadjuvant chemotherapy resulted in a 91.4% tumor size reduction (partial response).
- Complete surgical resection was achieved post-chemotherapy.
- Pathological examination confirmed large cell carcinoma of the thymus.
Implications:
- The ADOC regimen demonstrated significant efficacy in downstaging advanced thymic carcinoma.
- Neoadjuvant chemotherapy followed by resection is a viable strategy for resectable thymic carcinoma.
- This case highlights the potential of chemotherapy in managing aggressive thymic malignancies.
